Anti-Infective Agents Market (By Type: Antibacterials [Cephalosporins, Penicillin, Fluoroquinolones, Macrolides, Carbapenem, Others], Antivirals [Azoles, Echinocandins, Polyenes, Others], Antifungals; By Route of Administration: Topical, Oral, IV, Others; By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Specialty Pharmacies, E-Commerce, Others) - Global Industry Analysis, Market Size, Opportunities and Forecast, 2018 - 2026

Category : Healthcare and Pharmaceuticals | Delivery Format : PDF | Status: Published | Pages : 160

The global anti-infective agents market size estimated at nearly USD 144.9 billion by 2026. The global anti-infective agents market is likely to expand at a CAGR of more than 3.6% from 2018 to 2026.

Market Dynamics:

The rising predominance of irresistible illnesses, for example, HIV, H1N1, and Ebola infection mirror the significant changes in standards of conduct of networks over the ongoing decades. The societal changes and expanding mindfulness among medicinal services experts and patients are driving the growth. Broad R&D endeavors relating to the advancement of new medications with high viability and intensity against multi-sedate safe miniaturized scale living beings is one of the main considerations invigorating the growth.

For example, in 2016, the Food and Drug Administration (FDA) affirmed drugs, for example, Discovery by Gilead, for the treatment of HIV-1 contamination and Zephier by Merck that objectives constant Hepatitis C infection (HCV) genotypes 1 or 4 diseases in grown-ups.

Associations, for example, the World Health Organization (WHO) and Centers for Disease Control and Prevention (CDC) are effectively engaged with spreading mindfulness among individuals in regards to the lethal ramifications of irresistible illnesses and the significance of early treatment. The CDC has teamed up with the National Health Ministry (NHM) trying to spread mindfulness and to upgrade the treatment of transferable illnesses in creating nations, for example, Brazil, China, Nigeria, and India.

Nevertheless, the presentation of novel therapeutics with expanded strength and viability and the commercialization of pipeline items, for example, commercialization of Omadacycline in 2018 for the treatment of Community-Acquired Bacterial Pneumonia (CABP), are required to drive the growth of the anti-infective agents market. Most organizations are growing their item portfolios by concentrating on undiscovered chances. For example, Gilead propelled Sovaldi, the main ever oral prescription for the treatment of HCV genotype 2 and 3 out of 2013.

Market Insights:

Antiviral was evaluated to be the biggest portion with a market offer of 48.8% in 2018 inferable from the high cost related with the new intense anti-viral medications, for example, Vicriviroc for the treatment of HIV. The antibacterial portion is anticipated to enroll the quickest CAGR of 4.0% during the conjecture time frame, as antibacterial is the principal line of treatment for a vast scope of diseases. Expanded medicine and availability of antibacterial due to their over-the-counter status is anticipated to additionally drive the fragment.

Advancement of blend medications to treat and forestall genuine and hazardous diseases is relied upon to push the utilization of anti-infective medications. For example, in 2012, Gilead Sciences, Inc. propelled Stribild, a far-reaching treatment routine comprehensive of four medications (cobicistat, elvitegravir, emtricitabine, and tenofovirdisoproxilfumarate) utilized for the treatment of HIV patients without earlier retroviral treatment record.

The oral course of the organization was assessed to be the biggest portion in 2018 attributable to new item improvement and the nearness of solid item pipeline. Medical clinic drug store drove the anti-infective agents market in 2018 while the web-based business is relied upon to be the quickest developing fragment during the figure time frame. Viable illness the executives includes a scope of long haul methodologies, for example, new item advancement, mergers and acquisitions, co-improvement, and business extensions. For example, in 2015, ReViral got financing of USD 21 million for the improvement of its RV521 sedate by the Wellcome Trust.

Market Segmentation:

Market Segmentation by Type:

  • Antibacterials
    • Cephalosporins
    • Penicillin
    • Fluoroquinolones
    • Macrolides
    • Carbapenem
    • Others
  • Antivirals
    • Azoles
    • Echinocandins
    • Polyenes
    • Others
  • Antifungals

Market Segmentation by Route of Administration:

  • Topical
  • Oral
  • IV
  • Others

Market Segmentation by Distribution Channel:

  • Hospital Pharmacies
  • Retail Pharmacies
  • Specialty Pharmacies
  • E-Commerce
  • Others

Market Segmentation by Region:

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa

Regional Insights:

North America market was one of the main local markets regarding income in 2018. High pervasiveness of irresistible maladies incorporating clinic obtained contaminations in both, kids and grown-ups, and the resultant abuse of antibiotics combined with expanded availability of non-solution anti-infectives are the real drivers. The Asia Pacific is one of the quickest developing territorial market attributable to the nearness of high, neglected interest for novel medications, fast upgrades in medicinal services foundation combined with bringing issues to light among social insurance experts and patients.

Market Participants:

Major companies contributing the global anti-infective agents market are Abbott Laboratories, Astellas Pharma Inc., Bayer AG, Bristol-Myers Squibb Company, Gilead Sciences, Inc., GlaxoSmithKline plc., Johnson & Johnson Services, Inc., Merck & Co., Inc., Novartis AG, Pfizer, Inc., and Sanofi.


Related Reports

Open MRI Systems Market (By Field Strength: Low, Medium, High; By Application: Brain, Spine, Abdominal, Breast, Cardiac, Others) – Global Industry Analysis, Market Size, Opportunities and Forecast, 2019 - 2026

The global open MRI systems market is expected to grow at a CAGR of around 6.1% over the forecast period 2019 to 2026 and expected to reach the market value of around US$ 1,563.1 Mn by 2026. Magnetic resonance imaging (MRI) systems refer to the equipment which uses the medical imaging technique to form images of physiological processes of the body with the help of radiofrequency pu

Artificial Intelligence for Drug Discovery Market (By Drug Type: Small Molecule, Large Molecule; By Technology: Deep Learning, Machine Learning; By Application: Metabolic Disease, Cardiovascular Diseases, Oncology, Neurodegenerative Diseases, Others; By End use: Pharmaceutical & Biotechnological Companies, Academic & Research Institutes, Others) – Global Industry Analysis, Market Size, Opportunities and Forecast, 2019 - 2026

The Global Artificial Intelligence for Drug Discovery Market size is expected to reach around US$ 8,149 Mn by 2026 and is expected to register a CAGR of above 42%. There is constant increase in number of patients suffering from chronic diseases across the globe and pharmaceutical companies are investing high on development of various drugs. Artificial Intelligence is able to assist manufacturers by providing s

Healthcare Staffing Market By Service (Travel Nurse, Locum Tenens, Per Diem Nurse, Allied Healthcare) – Global Industry Analysis, Market Size, Opportunities And Forecast, 2019 - 2026

The global healthcare staffing market value is expected to reach around US$ 45.2 Bn by 2026 and growing at a CAGR of around 5.2% over the forecast period 2019 to 2026. Healthcare staffing agencies are the recruitment firms that provide a broad spectrum of healthcare staff ranging from nurse and physician to allied clinician and pharmacists. Healthcare facilities often need assistan

Ambulatory Surgical and Emergency Centers Market By Service Type (Orthopedics, Ophthalmology, Gastroenterology, Plastic Surgery, Pain Management or Spinal Injections, Others) – Global Industry Analysis, Market Size, Opportunities And Forecast, 2019 - 2026

The global ambulatory surgical and emergency centers market is expected to grow at a CAGR of 6.2% over the forecast period 2019 to 2026 and market size is poised to reach US$ 203.1 Bn by 2026. Ambulatory surgery and emergency centers are medical care facilities that provide same-day surgery care which also includes consultation and diagnosis. It is a more convenient alternative to hospital based outpatient pro

Ambulatory Health Care Services Market By Type (Primary Care Offices, Medical Specialty, Emergency Departments, Surgical Specialty), By Application (Orthopedics, Ophthalmology, Gastroenterology, Plastic Surgery, Pain Management or Spinal Injections, Others) – Global Industry Analysis, Market Size, Opportunities And Forecast, 2019 - 2026

The global ambulatory health care services market size is expected to surpass US$ 4.4 Tn by 2026 and will grow at a noteworthy CAGR of 5.9% over the forecast period 2019 to 2026. Ambulatory service centers (ASC) also referred as outpatient care centers. These are medical care facilities that provide outpatient services such as consultation, diagnosis, treatment, and intervention services. It is a more convenie

Ambulatory EHR Market By Application (Patient Management, Practice Management, E-prescribing, Population Health Management, Referral Management, Health Analytics, Decision Support), By Delivery Mode (Client Server-based, Web-based), By End User Mode (Independent Ambulatory Centers, Hospital-owned Ambulatory Centers) – Global Industry Analysis, Market Size, Opportunities And Forecast, 2019 - 2026

The global ambulatory EHR market size is expected to reach US$ 6.8 billion by 2026 and will grow at a CAGR of around 6.0% over the forecast period 2019 to 2026. The digital version of the patient’s record is known as the electronic health records. It includes a wide range of patient’s information such as medical history, ongoing medication, allergies, personal statistics, the status of immunization, demographics, and laborator

Cart Summary